CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 94 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $5,000 | -91.8% | 1,953 | -90.2% | 0.00% | – |
Q4 2020 | $61,000 | +258.8% | 19,988 | +635.4% | 0.00% | – |
Q3 2020 | $17,000 | -19.0% | 2,718 | -21.1% | 0.00% | – |
Q2 2020 | $21,000 | +75.0% | 3,445 | -28.6% | 0.00% | – |
Q1 2020 | $12,000 | -25.0% | 4,826 | -20.5% | 0.00% | – |
Q4 2019 | $16,000 | -74.6% | 6,074 | +17.3% | 0.00% | – |
Q3 2019 | $63,000 | -31.5% | 5,176 | -35.5% | 0.00% | – |
Q2 2019 | $92,000 | – | 8,030 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MFN Partners Management, LP | 1,487,874 | $17,036,000 | 2.70% |
BRIDGER MANAGEMENT, LLC | 1,032,633 | $11,824,000 | 0.93% |
EcoR1 Capital, LLC | 776,206 | $8,888,000 | 0.90% |
Camber Capital Management LP | 1,561,915 | $17,884,000 | 0.83% |
CVI Holdings, LLC | 157,114 | $1,798,000 | 0.70% |
Artal Group S.A. | 1,361,584 | $15,590,000 | 0.63% |
Slate Path Capital LP | 714,018 | $8,176,000 | 0.37% |
Sarissa Capital Management LP | 250,000 | $2,862,000 | 0.36% |
AWH Capital, L.P. | 10,107 | $116,000 | 0.17% |
Broderick Brian C | 32,919 | $377,000 | 0.13% |